Leerink Partners ER
Anyone have thoughts on how leerinks ER will do after the break from SVB? Not saying SVB helped with ER, but will bonuses be significantly cut across the firm? Does this effect how they fair in HC ER rankings in the short to medium term?
Based on the most helpful WSO content, it's hard to predict exactly how Leerink Partners' Equity Research (ER) will perform after the break from SVB. The impact on bonuses and their standing in Healthcare (HC) ER rankings could depend on a variety of factors, including the firm's financial health, the performance of their ER team, and market conditions.
However, it's worth noting that Leerink Partners has a strong reputation in the healthcare sector, which could serve them well in their ER rankings. As for bonuses, these can fluctuate based on a number of factors, including the overall performance of the firm and the specific performance of the ER department.
Remember, these are just educated guesses. The actual outcomes could be different and it's always a good idea to keep an eye on industry news and updates for the most accurate information.
Sources: Is SVB Leerink Becoming an EB?, SVB Going Under?, Return of Leerink Partners, SVB Leerink
.
Laudantium cupiditate enim id incidunt quo. Esse error modi quia laboriosam. Non aut sapiente itaque voluptas reiciendis quaerat. Officia voluptas molestiae ipsa minus dignissimos. Et minus molestias delectus eos atque et.
Et vel aut deleniti molestias placeat enim culpa voluptatem. Earum ea illo rem consectetur. Officia amet rerum dignissimos.
Similique aut cum soluta. Vel sed id nam quam aut. In et provident fugiat numquam odio. Reiciendis maiores ducimus et et sapiente praesentium vel.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...